Healthcare [ 2/11 ] | Health Information Services [ 98/154 ]
US | NASDAQ | Stock
Reported Date | EPSChange YoY | EstimateSurprise |
---|---|---|
Nov 10, 22 | 0.76 | -0.25
Increased by
+404.00%
|
Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
---|---|---|---|
Sep 30, 22 | 82.00 K
Increased by
+N/A%
|
53.24 M
Increased by
+37.23 M%
|
Increased by
+64.92 K%
Decreased by
N/A%
|
Jun 30, 22 | 0.00 - | -1.73 M - |
Decreased by
N/A%
-
|
Mar 31, 22 | 0.00 - | -4.18 M - |
Decreased by
N/A%
-
|
Sep 30, 21 | 0.00 - | -260.31 K - |
Decreased by
N/A%
-
|
Jun 30, 21 | 0.00 - | -143.00 - |
Decreased by
N/A%
-
|
Rank | ETF | Shares | Market Value | Weight % in ETF |
---|
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.